Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Kahn

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
International Journal of Epidemiology|February 12, 2008
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical SystemsMari M Kitahata, Benigno Rodriguez, Richard Haubrich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Seroconversion following nonoccupational postexposure prophylaxis against HIVMichelle E Roland, Torsten B Neilands, Melissa R Krone, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2013
Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical careMonica A Muñoz, Wei Liu, Joseph A C Delaney, et al.
JAMA|July 13, 2000
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trialR T Davey, R L Murphy, F M Graziano, et al.
The Journal of Experimental Medicine|January 10, 2001
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infectionM Altfeld, E S Rosenberg, R Shankarappa, et al.
AIDS (London, England)|December 20, 2003
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infectionMarcus Altfeld, Marylyn M Addo, Eric S Rosenberg, et al.
The Journal of Infectious Diseases|October 1, 1996
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 TeamS L Welles, J B Jackson, B Yen-Lieberman, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
International Journal of Epidemiology|February 12, 2008
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical SystemsMari M Kitahata, Benigno Rodriguez, Richard Haubrich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Seroconversion following nonoccupational postexposure prophylaxis against HIVMichelle E Roland, Torsten B Neilands, Melissa R Krone, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2013
Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical careMonica A Muñoz, Wei Liu, Joseph A C Delaney, et al.
JAMA|July 13, 2000
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trialR T Davey, R L Murphy, F M Graziano, et al.
The Journal of Experimental Medicine|January 10, 2001
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infectionM Altfeld, E S Rosenberg, R Shankarappa, et al.
AIDS (London, England)|December 20, 2003
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infectionMarcus Altfeld, Marylyn M Addo, Eric S Rosenberg, et al.
The Journal of Infectious Diseases|October 1, 1996
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 TeamS L Welles, J B Jackson, B Yen-Lieberman, et al.
Pageof 9